Core Insights - High Tide Inc. has achieved significant milestones in 2025, including surpassing 200 stores and entering the German medical cannabis market, while maintaining strong financial performance [1][2][3] Company Performance - The company reported over $2 billion in cumulative sales since cannabis legalization in Canada, with an annualized revenue run-rate of $600 million as of the last reported quarter [3][4] - High Tide ended 2025 with an annualized Adjusted EBITDA run-rate exceeding $42 million, driven by a 7.4% increase in same-store sales in Q3 2025 [4] - The retail sales per square foot across the Canna Cabana store network reached $1,735, outperforming many leading retailers [4] Market Position - High Tide holds a 12% market share in the retail cannabis sector across five Canadian provinces, reinforcing its position as a market leader [4][6] - The company added 27 new Canna Cabana locations in Canada in 2025, achieving its goal of opening 20 to 30 locations [4] Brand and Loyalty Program - The Cabana Club membership surpassed 2.4 million members, including 139,000 ELITE members, making it the largest cannabis loyalty program globally [4] - High Tide's Canna Cabana brand is recognized as the most prominent cannabis retail brand in Canada, with 218 stores [4][6] International Expansion - The company successfully entered the German medical cannabis market by acquiring a majority stake in Remexian Pharma GmbH, positioning itself as a major importer and distributor in Germany [4][7] - High Tide aims to expand its global footprint and strengthen its brand presence, with potential future expansion into the United States [3][4]
High Tide Recaps Key Milestones of 2025